Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Doxorubicin-mediated radiosensitivity in multicellular spheroids from a lung cancer cell line is enhanced by composite micelle encapsulation.

Xu WH, Han M, Dong Q, Fu ZX, Diao YY, Liu H, Xu J, Jiang HL, Zhang SZ, Zheng S, Gao JQ, Wei QC.

Int J Nanomedicine. 2012;7:2661-71. doi: 10.2147/IJN.S30445. Epub 2012 May 29.

2.

Doxorubicin encapsulated in micelles enhances radiosensitivity in doxorubicin-resistant tumor cells.

Xu W, Han M, Diao Y, Pan T, Ge W, Liu H, He H, Jiang H, Zheng S, Zhang S, Gao J, Wei Q.

Discov Med. 2014 Oct;18(99):169-77.

3.

Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle.

Han M, Diao YY, Jiang HL, Ying XY, Chen DW, Liang WQ, Gao JQ.

Int J Pharm. 2011 Nov 28;420(2):404-11. doi: 10.1016/j.ijpharm.2011.09.009. Epub 2011 Sep 16.

PMID:
21945184
4.

Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.

Perche F, Patel NR, Torchilin VP.

J Control Release. 2012 Nov 28;164(1):95-102. doi: 10.1016/j.jconrel.2012.09.003. Epub 2012 Sep 10.

5.

The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles.

Kim TH, Mount CW, Gombotz WR, Pun SH.

Biomaterials. 2010 Oct;31(28):7386-97. doi: 10.1016/j.biomaterials.2010.06.004. Epub 2010 Jul 3.

PMID:
20598741
6.

Chemosensitivity of radioresistant cells in the multicellular spheroids of A549 lung adenocarcinoma.

Shi D, Shi G, Huang G, Zhang J, Lartigau E.

J Exp Clin Cancer Res. 2009 Jun 2;28:72. doi: 10.1186/1756-9966-28-72.

7.

Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer.

Gu Y, Li J, Li Y, Song L, Li D, Peng L, Wan Y, Hua S.

Int J Nanomedicine. 2016 Nov 3;11:5757-5770. eCollection 2016.

8.

Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer.

Wang K, Liu L, Zhang T, Zhu YL, Qiu F, Wu XG, Wang XL, Hu FQ, Huang J.

Int J Nanomedicine. 2011;6:3207-18. doi: 10.2147/IJN.S26268. Epub 2011 Dec 6.

9.

Doxorubicin-loaded PEG-PCL copolymer micelles enhance cytotoxicity and intracellular accumulation of doxorubicin in adriamycin-resistant tumor cells.

Diao YY, Li HY, Fu YH, Han M, Hu YL, Jiang HL, Tsutsumi Y, Wei QC, Chen DW, Gao JQ.

Int J Nanomedicine. 2011;6:1955-62. doi: 10.2147/IJN.S23099. Epub 2011 Sep 12.

10.

A strategy in the design of micellar shape for cancer therapy.

Chen T, Guo X, Liu X, Shi S, Wang J, Shi C, Qian Z, Zhou S.

Adv Healthc Mater. 2012 Mar;1(2):214-24. doi: 10.1002/adhm.201100040. Epub 2012 Feb 16.

PMID:
23184725
11.

The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles.

Min KH, Lee HJ, Kim K, Kwon IC, Jeong SY, Lee SC.

Biomaterials. 2012 Aug;33(23):5788-97. doi: 10.1016/j.biomaterials.2012.04.057. Epub 2012 May 15.

PMID:
22591612
12.

Fabrication and characterization of nuclear localization signal-conjugated glycol chitosan micelles for improving the nuclear delivery of doxorubicin.

Yu J, Xie X, Zheng M, Yu L, Zhang L, Zhao J, Jiang D, Che X.

Int J Nanomedicine. 2012;7:5079-90. doi: 10.2147/IJN.S36150. Epub 2012 Sep 21.

13.
14.

Novel micelles from graft polyphosphazenes as potential anti-cancer drug delivery systems: drug encapsulation and in vitro evaluation.

Zheng C, Qiu L, Yao X, Zhu K.

Int J Pharm. 2009 May 21;373(1-2):133-40. doi: 10.1016/j.ijpharm.2009.01.025. Epub 2009 Feb 7.

PMID:
19429298
15.

Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation.

Chen L, Sha X, Jiang X, Chen Y, Ren Q, Fang X.

Int J Nanomedicine. 2013;8:73-84. doi: 10.2147/IJN.S38221. Epub 2013 Jan 3.

16.

Characterization and anti-tumor activity of chemical conjugation of doxorubicin in polymeric micelles (DOX-P) in vitro.

Zhao YZ, Sun CZ, Lu CT, Dai DD, Lv HF, Wu Y, Wan CW, Chen LJ, Lin M, Li XK.

Cancer Lett. 2011 Dec 8;311(2):187-94. doi: 10.1016/j.canlet.2011.07.013. Epub 2011 Aug 5.

PMID:
21872982
17.

Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment.

Duong HH, Yung LY.

Int J Pharm. 2013 Sep 15;454(1):486-95. doi: 10.1016/j.ijpharm.2013.06.017. Epub 2013 Jun 21.

PMID:
23792465
18.

Cytostatic effect of xanthone-loaded mPEG-b-p(HPMAm-Lac2) micelles towards doxorubicin sensitive and resistant cancer cells.

Khonkarn R, Mankhetkorn S, Talelli M, Hennink WE, Okonogi S.

Colloids Surf B Biointerfaces. 2012 Jun 1;94:266-73. doi: 10.1016/j.colsurfb.2012.02.002. Epub 2012 Feb 10.

PMID:
22377215
19.
20.

Oxime linkage: a robust tool for the design of pH-sensitive polymeric drug carriers.

Jin Y, Song L, Su Y, Zhu L, Pang Y, Qiu F, Tong G, Yan D, Zhu B, Zhu X.

Biomacromolecules. 2011 Oct 10;12(10):3460-8. doi: 10.1021/bm200956u. Epub 2011 Sep 7.

PMID:
21863891

Supplemental Content

Support Center